Capricor Therapeutics, Inc.

Historical 13F Holders

Symbol
CAPR
CUSIP
14070B309
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 14070B309 since 12/18/2024, largest first.

Filer % of Class Filed
Tang Capital Management LLC 13G/A
7.1% 8/14/2026
Event 6/30/2026
Suvretta Capital Management, LLC 13G
6.6% 2/26/2026
Event 2/19/2026
BlackRock, Inc. 13G/A 6.5% 2/5/2025
Event 12/31/2024
State Street Corp 13G 5.9% 8/7/2026
Event 6/30/2026
RA Capital Management, L.P. 13G
5.2% 8/3/2026
Event 7/27/2026
Millennium Management LLC 13G
5.1% 9/14/2026
Event 9/8/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Vanguard Group Inc 13G/A 4.8% 10/30/2025
Event 9/30/2025
Highbridge Capital Management, LLC 13G/A 2.3% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 2.85 k $27.0 k
2026 Q2 195 40.8 M $1.00 B
2026 Q1 198 33.9 M $1.03 B
2025 Q4 151 27.4 M $791 M
2025 Q3 142 14.6 M $105 M
2025 Q2 141 13.8 M $137 M
2025 Q1 144 18.3 M $174 M
2024 Q4 136 17.3 M $239 M
2024 Q3 96 8.43 M $128 M
2024 Q2 72 6.52 M $31.1 M
2024 Q1 66 5.13 M $34.8 M
2023 Q4 44 4.08 M $20.0 M
2023 Q3 39 5.54 M $18.9 M
2023 Q2 38 2.62 M $12.5 M
2023 Q1 35 2.43 M $10.3 M
2022 Q4 40 2.82 M $10.9 M
2022 Q3 39 2.79 M $16.8 M
2022 Q2 38 2.54 M $8.87 M
2022 Q1 38 2.59 M $8.95 M
2021 Q4 36 2.54 M $7.43 M
2021 Q3 39 2.49 M $10.0 M
2021 Q2 40 3.53 M $18.1 M
2021 Q1 39 4.38 M $20.5 M
2020 Q4 37 1.68 M $5.76 M
2020 Q3 34 1.26 M $6.64 M
2020 Q2 38 941 k $4.32 M
2020 Q1 20 500 k $598 k
2019 Q4 19 232 k $295 k
2019 Q3 16 124 k $460 k
2019 Q2 13 85.4 k $283 k